INmune Bio Inc. (INMB)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
9.10
1.08 (13.47%)
At close: Jan 29, 2025, 3:59 PM
9.20
1.10%
After-hours Jan 29, 2025, 07:45 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
Net Income | -30.01M | -27.30M | -30.34M | -12.10M | -7.68M | -12.44M | -831.49K | -277.49K | -48.87K |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 7.37M | 7.15M | 4.80M | 3.11M | 4.10M | 10.00M | 199.56K | n/a | 120.00K |
Other Working Capital | 1.70M | -4.27M | -5.35M | -1.03M | -129.21K | -134.38K | -218.81K | -309.95K | 750.00 |
Other Non-Cash Items | 224.00K | 328.00K | 126.00K | 3.19M | -1.54M | 9.81M | -150.00K | 50.00K | 30.00K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 10.44M | -2.86M | -3.09M | 43.51K | -260.88K | 379.67K | 20.10K | -89.89K | 750.00 |
Operating Cash Flow | -11.98M | -22.69M | -28.50M | -8.94M | -5.38M | -2.06M | -761.83K | -317.38K | -18.12K |
Capital Expenditures | n/a | n/a | -15.00M | n/a | n/a | n/a | -100.00K | n/a | n/a |
Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -15.00M | n/a | n/a | n/a | -100.00K | n/a | n/a |
Investing Cash Flow | n/a | n/a | -15.00M | n/a | n/a | n/a | -100.00K | n/a | n/a |
Debt Repayment | -5.00M | n/a | 14.95M | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -1.01M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 30.00K | 1.15M | n/a | n/a | n/a | n/a | 350.00K | 120.00K |
Financial Cash Flow | -4.22M | 729.00K | 96.36M | 23.89M | 12.21M | 900.00K | 2.06M | 450.00K | 30.00K |
Net Cash Flow | -16.30M | -22.66M | 52.84M | 14.97M | 6.81M | -1.18M | 1.23M | 129.78K | 11.88K |
Free Cash Flow | -11.98M | -22.69M | -43.50M | -8.94M | -5.38M | -2.06M | -861.83K | -317.38K | -18.12K |